Clinical Trial Update: Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar [Phase 2]

View source ↗

Summary

Phase 2 study evaluating radiation therapy plus Bexxar (tositumomab) for relapsed follicular non-Hodgkin's lymphoma; the trial was terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Bexxar (tositumomab)

Snippet

Sponsor: University of Florida | Conditions: Non-Hodgkin's Lymphoma, Follicular Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2012-02-15